To elucidate the precise mechanisms by which AMD3100 inhibits AF development, we also examined the CXCR4-dependent AKT/mTOR and ERK1/2 pathways, which are important regulators of fibrogenesis. This evidence concerns the gene MAPK3 and atrial fibrillation.